This statistic depicts the global cancer immunotherapy sales distribution in 2014 and a projection for 2021, by type. Therapeutic vaccines made up some 15 percent of global cancer immunotherapy sales in 2014. This share is expected to decrease to around four percent by 2021.
Global cancer immunotherapy sales share by type 2014 and 2021 forecast
Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Number of cancer immunotherapy companies by country of origin 2015
- New targeted cancer immunotherapies available in selected countries 2015
- Distribution of cancer immunotherapies by technology 2015
- Oncology treatment modality changes worldwide 2003 and 2013
- Share of oncology biologics and non-biologic market 2003-2013
- Distribution of active oncology products along the drug pipeline February 2014
- Number of active oncology products along the pipeline in BRIC countries 2014
- Oncology spending in selected developed countries 2015
- Number of oncology NMEs launched by biologics and non-biologic 2004-2013
- Global market forecast of oncologics and supportive care biosimilars 2020
- Net price index for cancer products in developed markets 2014
- Oncology spending as share of pharmaceutical spending by country 2015
- Oncology spending worldwide by region 2015 vs. 2020
- U.S. average invoice price increase for oncology brands 2012-2017
- Share of Canadians leaving the country for radiation oncology in 2016, by province
- Usage of electronic health records at oncology practices in the U.S. 2012-2013
- Oncology therapeutic spending growth 2013-2018 U.S. vs pharmerging
- Number of oncology practices in the U.S. by region and size 2013
Further related statistics
DCAT. (March 14, 2016). Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type [Graph]. In Statista. Retrieved December 11, 2019, from https://www.statista.com/statistics/670707/percentage-of-cancer-immunotherapy-sales-by-type-worldwide/
DCAT. "Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type." Chart. March 14, 2016. Statista. Accessed December 11, 2019. https://www.statista.com/statistics/670707/percentage-of-cancer-immunotherapy-sales-by-type-worldwide/
DCAT. (2016). Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type. Statista. Statista Inc.. Accessed: December 11, 2019. https://www.statista.com/statistics/670707/percentage-of-cancer-immunotherapy-sales-by-type-worldwide/
DCAT. "Global Cancer Immunotherapy Sales Distribution in 2014 and Projection for 2021, by Type." Statista, Statista Inc., 14 Mar 2016, https://www.statista.com/statistics/670707/percentage-of-cancer-immunotherapy-sales-by-type-worldwide/
DCAT, Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by type Statista, https://www.statista.com/statistics/670707/percentage-of-cancer-immunotherapy-sales-by-type-worldwide/ (last visited December 11, 2019)